Palatin Technologies
PTN
#9923
Rank
NZ$67.78 M
Marketcap
NZ$39.81
Share price
4.59%
Change (1 day)
2,418.16%
Change (1 year)

Palatin Technologies (PTN) - Total assets

Total assets on the balance sheet as of March 2025 : NZ$6.45 Million

According to Palatin Technologies's latest financial reports the company's total assets are NZ$6.45 Million. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Palatin Technologies - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-06-30NZ$17.61 M-39.78%
2023-06-30NZ$29.24 M-49.4%
2022-06-30NZ$57.8 M-39.9%
2021-06-30NZ$96.18 M-27.05%
2020-06-30NZ$0.13 B-15.37%
2019-06-30NZ$0.15 B170.39%
2018-06-30NZ$57.61 M-25.78%
2017-06-30NZ$77.62 M410.2%
2016-06-30NZ$15.21 M-64.96%
2015-06-30NZ$43.42 M203%
2014-06-30NZ$14.33 M-55.77%
2013-06-30NZ$32.4 M383.33%
2012-06-30NZ$6.7 M-73.77%
2011-06-30NZ$25.55 M42.71%
2010-06-30NZ$17.91 M-13.01%
2009-06-30NZ$20.58 M-18.1%
2008-06-30NZ$25.13 M-54.83%
2007-06-30NZ$55.65 M-15.84%
2006-06-30NZ$66.12 M28.61%
2005-06-30NZ$51.41 M18.28%
2004-06-30NZ$43.46 M11.38%
2003-06-30NZ$39.02 M53.48%
2002-06-30NZ$25.42 M-27.42%
2001-06-30NZ$35.03 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
MediciNova
MNOV
NZ$86.24 M 1,236.30%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
NZ$10.37 M 60.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
NZ$7.38 B 114,308.25%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
NZ$2.43 B 37,667.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$2.55 B 39,507.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$333.76 B 5,171,323.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
NZ$0.84 B 12,939.33%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$198.12 B 3,069,668.19%๐Ÿ‡ฌ๐Ÿ‡ง UK